Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001

NCT03004495 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Copd

Interventions

DRUG: CHF5259 and CHF6001
DRUG: CHF5259 + placebo
DRUG: CHF6001 + placebo
OTHER: Placebo

Sponsor

Chiesi Farmaceutici S.p.A.

Collaborators

[object Object]